LADRX
Live / Applied — Fourth extension granted (statement of use) (as of 26 Sept 2025)
What this means for you
Not registered yet, but its 09 Sept 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97584795
- Mark type
- Stylized text
- Filed
- 09 Sept 2022
- Published for opposition
- 01 Aug 2023
- Attorney of record
- Jason S. Ingerman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer
- Class 042 — Scientific and technological services: Pharmaceutical products development; Pharmaceutical research and development; Development of pharmaceutical preparations for the treatment of cancer
Owner
- CytRx Corporation, Los Angeles, CA, US
- CytRx Corporation, Los Angeles, CA, US
Prosecution history
- 26 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Sept 2025 — SOU EXTENSION 4 GRANTED
- 26 Sept 2025 — SOU EXTENSION 4 FILED
- 26 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 21 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Mar 2025 — SOU EXTENSION 3 GRANTED
- 20 Mar 2025 — SOU EXTENSION 3 FILED
- 20 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Sept 2024 — SOU EXTENSION 2 GRANTED
- 26 Sept 2024 — SOU EXTENSION 2 FILED
- 26 Sept 2024 — SOU TEAS EXTENSION RECEIVED
- 13 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Mar 2024 — SOU EXTENSION 1 GRANTED
- 12 Mar 2024 — SOU EXTENSION 1 FILED